As the Michelle Carter trial continues this week, her defense team presented expert witnesses; Dr. Peter Breggin took the stand testifying in regards to his knowledge on the effects felt by juveniles whom are prescribed antidepressants. This comes after the defense had their motion to dismiss the case, for lack of credible evidence, denied. A witness for the defense, Dr. Breggin has frequently testified in court cases, roughly 90 times since the 1980’s, and is commonly known for his opposition of anti-depressant medications.
For roughly four hours, Dr. Breggin described Michelle Carter as a person always willing to offer a helping hand who underwent changes after being prescribed the well known antidepressant Prozac and subsequently Celexa. Dr. Breggin painted a picture of a young adult who simply was suffering from the side effects of the medication she was placed on, noting that antidepressants, such as the medications listed above, have the ability to affect impulse control. He also pointed out some of the warnings, in plain view, on the side of the Celexa medication bottle itself; warnings such as potential for an increased risk of suicide for those taking the medicine.
After first being prescribed Prozac, Breggin noted that it was evident to Carters loved ones that she was becoming increasingly more vulnerable. He gave his expert opinion, citing the many common side effects patients that take similar drugs commonly feel. Prozac was the first medication that was prescribed to Carter whom later switched her medications in July of 2014. After switching her medication to Celexa, Carter began to exhibit more apathy, but this apathy was also coupled with bursts of anger and mania. Dr. Breggin highlighted the drugs effect on the frontal lobe, specifically in young adults, noting that the drug may negatively impact her ability to make proper choices and to fully understand the consequences of such choices.